MiMedx Group Inc. received a delinquency notice from the Nasdaq Stock Market for failure to file a periodic report.
The company had not yet filed its Form 10-K for the year ended Dec. 31, 2017.
The Marietta, Ga.-based company said it will submit a plan to regain compliance within the required 60 days. If Nasdaq accepts the plan, it can exempt the company from being delisting for up to 180 calendar days from the Form 10-K's due date, or until Aug. 28.
The notice has no immediate effect on the Nasdaq listing of MiMedx, which develops regenerative biomaterial products and bioimplants.
